赛妥珠单抗诱发点滴状银屑病样皮炎。

Certolizumab-induced guttate psoriasiform dermatitis.

作者信息

Fischer Ryan, DaCunha Matthew, Rajpara Anand

机构信息

Division of Dermatology, University of Kansas Medical Center, Kansas City.

出版信息

Dermatol Online J. 2017 Jan 15;23(1):13030/qt0197d9gk.

PMID:28329474

Abstract

Certolizumab is a TNF inhibitor that has showngreat efficacy in chronic inflammatory diseases. Wereport a patient exhibiting a novel adverse effect ofcertolizumab: drug-induced guttate psoriasiformeruption. A review of the mechanism of psoriasiformdrug eruptions is also included.

摘要

赛妥珠单抗是一种肿瘤坏死因子抑制剂，已在慢性炎症性疾病中显示出显著疗效。我们报告了一例出现赛妥珠单抗新不良反应的患者：药物性点滴状银屑病样皮疹。本文还包括对银屑病样药物疹发病机制的综述。